These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16449685)

  • 1. Implementation of a statewide outcome monitoring system: lessons learned from substance abuse treatment provider staff.
    Teruya C; Hardy M; Hser YI; Evans E
    Qual Health Res; 2006 Mar; 16(3):337-52. PubMed ID: 16449685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Painting a picture of the client": implementing the Addiction Severity Index in community treatment programs.
    Spear SE; Brown AH; Rawson RA
    J Subst Abuse Treat; 2005 Dec; 29(4):277-82. PubMed ID: 16311180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental health quality and accountability: the role of evidence-based practices and performance measurement.
    Ganju V
    Adm Policy Ment Health; 2006 Nov; 33(6):659-65. PubMed ID: 17053978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organizational readiness for change in community-based addiction treatment programs and adherence in implementing evidence-based practices: a national study.
    Lundgren L; Amodeo M; Chassler D; Krull I; Sullivan L
    J Subst Abuse Treat; 2013; 45(5):457-65. PubMed ID: 23928378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of routine outcome measures: staff reactions and issues for consideration.
    Meehan T; McCombes S; Hatzipetrou L; Catchpoole R
    J Psychiatr Ment Health Nurs; 2006 Oct; 13(5):581-7. PubMed ID: 16965478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructive conflict and staff consensus in substance abuse treatment.
    Melnick G; Wexler HK; Chaple M; Cleland CM
    J Subst Abuse Treat; 2009 Mar; 36(2):174-82. PubMed ID: 18657943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug treatment program compliance and resistance activities during implementation of California's Proposition 36.
    Reynolds G
    J Health Hum Serv Adm; 2009; 32(1):85-106. PubMed ID: 19558034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse prevention infrastructure: a survey-based study of the organizational structure and function of the D.A.R.E. program.
    Merrill JC; Pinsky I; Killeya-Jones LA; Sloboda Z; Dilascio T
    Subst Abuse Treat Prev Policy; 2006 Sep; 1():25. PubMed ID: 16956400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve questions to ask about your outcomes monitoring system--Part I.
    Balsamo RR; Pine M
    Physician Exec; 1994 Apr; 20(4):13-6. PubMed ID: 10133528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allocation of substance use disorder patients to appropriate levels of care: feasibility of matching guidelines in routine practice in Dutch treatment centres.
    Merkx MJ; Schippers GM; Koeter MJ; Vuijk PJ; Oudejans S; de Vries CC; van den Brink W
    Addiction; 2007 Mar; 102(3):466-74. PubMed ID: 17298655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider and patient perspectives regarding health care for war-related health concerns.
    Davis JD; Engel CC; Mishkind M; Jaffer A; Sjoberg T; Tinker T; McGough M; Tipton S; Armstrong D; O'Leary T
    Patient Educ Couns; 2007 Sep; 68(1):52-60. PubMed ID: 17537612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical considerations for the implementation of health outcome measures.
    Carriere RS
    Stud Health Technol Inform; 2009; 143():198-201. PubMed ID: 19380936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
    Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
    Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organizational- and individual-level correlates of posttreatment substance use: a multilevel analysis.
    Ghose T
    J Subst Abuse Treat; 2008 Mar; 34(2):249-62. PubMed ID: 17600654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a continuous quality improvement program for percutaneous coronary intervention and cardiac surgery at a large community hospital.
    Brush JE; Balakrishnan SA; Brough J; Hartman C; Hines G; Liverman DP; Parker JP; Rich J; Tindall N
    Am Heart J; 2006 Aug; 152(2):379-85. PubMed ID: 16875926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary comparison of major kinds of obstacles to enrolling in substance abuse treatment (AOD) reported by injecting street outreach clients and other stakeholders.
    Appel PW; Oldak R
    Am J Drug Alcohol Abuse; 2007; 33(5):699-705. PubMed ID: 17891662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practitioners' attitudes concerning evidence-based guidelines in Belgian substance abuse treatment.
    Autrique M; Vanderplasschen W; Broekaert E; Sabbe B
    Eur Addict Res; 2009; 15(1):47-55. PubMed ID: 19052462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers.
    McGovern MP; Xie H; Segal SR; Siembab L; Drake RE
    J Subst Abuse Treat; 2006 Oct; 31(3):267-75. PubMed ID: 16996389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.